Bioengineered Protein Drugs Market: By Drug Type (Vaccines, Peptide hormones, Blood Products, Monoclonal antibodies, Recombinant protein drugs, Replacement proteins, Peptide antibiotics, Therapeutic enzymes, Cytokines), By Technology (Bioreactors and microbial cell fermentation, Genetically modified organisms, Fractionation, Pharming, Others), By Application (Diabetes, Heart diseases, Neurodegenerative diseases, Respiratory diseases, Infectious diseases, Congenital diseases, Others), By Drug delivery (Traditional methods, Novel Methods), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global bioengineered protein drugs market size valued 150.5 billion in 2020, growing at a CAGR of 3.4% during the forecast period 2021-2027. Bioengineered proteins are formulated as the fundamental participants in the biological process. They are target specific and have lesser side effects which leads to higher acceptance when compared to that of a small molecule. Bioengineered Protein Drugs Market act as the powerful therapeutic agents. They include a wide range of products such as monoclonal antibodies, cytokines, growth factors, and many. Due to various factors such as bio-reactivity, safety, and success rate bioengineered proteins are gaining popularity all across the healthcare industry.

Bioengineered Protein Drugs Market Summary

Study Period


Base Year




Largest Market

Asia Pacific

Fastest Growing Market

North America
Bioengineered Protein Drugs Market Dynamics

Increase in prevalence of chronic diseases such as diabetics, cancer etc. is one of the major factor responsible for the growth of the bioengineered protein drugs market. According to the WHO, the diabetic population is expected to grow by 366 million by 2030. The technological advancements in the drug delivery system and noticeable manufacturing developments in the biopharmaceutical industry is likely to drive the growth of the bioengineered protein drugs market over the forecast period. The minimal side effects of the bioengineered protein drugs also boosting the growth of the market. However, the higher cost of the drugs is likely to hamper the growth of the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Bioengineered Protein Drugs Market Segmentation

drug type
  • Vaccines
    • Subunit/Conjugate
    • Toxoid
    • Live Attenuated Vaccines
    • Inactivated/Killed Vaccines
  • Peptide Hormones
    • Growth Hormones
    • Erythropoietin
    • Insulin
    • Luteinizing Hormones
    • Follicle Stimulating Hormones
  • Blood Products
    • Coagulation Factors
    • Thrombin
    • Immune Globulins
    • C1 Esterase Inhibitor
    • Alpha 1-Protease Inhibitor
    • Antithrombin
  • Monoclonal Antibodies
  • Recombinant Protein Drugs
  • Replacement Proteins
  • Peptide Antibiotics
  • Therapeutic Enzymes
    • Metabolic Enzymes
    • Digestive Enzymes
    • Others
  • Cytokines
    • Interferons
    • Interleukins
    • Colony stimulating factors
By Technology
  • Bioreactors and Microbial Cell Fermentation
  • Genetically Modified Organisms
  • Fractionation
  • Pharming
  • Others
By Application
  • Diabetes
  • Heart Diseases
  • Neurodegenerative Diseases
  • Respiratory Diseases
  • Infectious Diseases
  • Congenital Diseases
  • Others
drug delivery
  • Traditional methods
  • Novel Methods


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Abbott Laboratories (U.S)
  • Amgen (U.S)
  • Merck & Co., Inc. (U.S)
  • Allergan (Ireland)
  • Eli Lilly and Company (U.S)
  • Johnson & Johnson (U.S)
  • Panacea Biotec (India)
  • GlaxoSmithKline plc (U.K)
  • Hoffmann-La Roche (Switzerland)